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Free-Radical-Mediated DNA Binding
by Peter J. O'Brien*
Free-radical metabolites can be generated metabolically by a one-electron reductase-catalyzed reaction
or a "peroxidase" catalyzed oxidation or by photoactivation of a wide variety of aromatic xenobiotics.
Radicals may also be generated during lipid peroxidation. Some radicals can react with DNA or bind
covalently or noncovalently as a dismutation product or as a dimer, trimer or polymeric product. Modi-
fication to the DNA can result in singlestrand breaks, loss of template activity, and crosslinking. The
binding can prevent enzymic digestion. In some cases, the radicals react with oxygen, resulting before
conversion to DNA reactive oxygen species. Most radicals probably do not interact with DNA.
Introduction
As a result of the realization in the early 1940s that
free radicals produced by ionizing radiation and ultra-
violet radiation can lead to carcinogenesis, there has
been interest in the possibility that free-radical metab-
olites ofxenobiotics are possible toxic intermediates or
proximate carcinogens. The most widely accepted the-
ory for the initiation of processes leading to carcino-
genesis isthatcarcinogens elicittheir activity after con-
version to electrophiles that interact with anucleophilic
region of a macromolecule. Binding to DNA in a way
that causes errors in replication during cell division
could result in initiation. Subsequent proliferation of
these cells may lead to the neoplasmic state. It would
beexpected that suchbinding should resultin aminimal
change in the physical structure of the DNA so as to
avoid setting into motion the highly effective in vivo
repair mechanisms. On the other hand, cytotoxicity
could also occur ifthe binding to DNA prevents normal
repair processes and the damage to the DNA results in
an inhibition of RNA synthesis or DNA replication. In
the case ofthe toxic and carcinogenic effects ofirradia-
tion, the importance of free-radical interactions with
DNA have been reviewed previously (1).
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The metabolic activation of chemical carcinogens in
theliverisgenerallythoughtnotto involve free radicals
butratherelectrophiles, e.g., nitrenium ions in the case
of arylamines, carbonium ions in the case ofpolycyclic
aromatic hydrocarbons. The first step in this activation
is believed to involve atwo-electron oxidation catalyzed
by a cytochrome P-450-dependent mixed-function oxi-
dase of the arylamine to the N-hydroxyarylamine and
thepolycyclic aromatichydrocarbon to an epoxide. Fur-
thermore, the structure ofthe DNA adducts formed in
the liver and some other target organs in vivo is iden-
tical to that formed in vitro with the proximate carcin-
ogen formed by this pathway (2). However, one-elec-
tron oxidative or reductive activation of carcinogens
involving free radicals and leading to extensive DNA
binding has been proposed by various investigators for
different carcinogens and certain target organs. The
enzyme catalysts involved include peroxidases, pros-
taglandin synthetase and various reductases. In most
nonhepatictissues, theseactivities are oftenmuch more
active thanmixed function oxidase activity. Reviews on
theprostaglandin synthetasecatalyzedmechanismhave
appeared (3,4). There are also reviews available com-
paring one-electron and two-electron oxidative mecha-
nisms for carcinogenic arylamines (5) and polycyclic ar-
omatic hydrocarbons (6). Reductase catalyzed
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icals have also been reviewed (7,8).
Several investigators, however, believe that target
tissues activate the detoxified conjugates released from
the liver and transported in the blood or bile, e.g., by
enzymic hydrolysis (9).
The present paper reviews various studies on DNA
interactions with the free radicals ofoxygen, anticancer
drugs, mutagenicdyes, andawiderangeofcarcinogens.
The reactive radicals can be generated from these com-
poundsbyreductive oroxidative metabolism orin some
cases, by reductive or oxidative photoactivation. Oxy-
gen radicals can also be generated by autoxidation of
these radicals orotherreduced metabolites. The nature
ofthe DNAproductsformed andtheeffects ontheDNA
secondary and tertiary structure and consequences on
DNA function are also discussed.
Noncovalent Binding
Many small positively charged molecules interact
with nucleic acids. One general class of compounds
which seem tointercalate between the bases inthe dou-
ble helix are those compounds with the structure I,
I
For acridines, X = N, Y = C; for phenazines, X = N,
Y = N; phenothiazines, X = N, Y = S; actinomycin,
X = N, Y = 0. When base specificity is determined
by differential dialysis of DNA bound by a series of
proflavine and acridine orange analogs against DNA
samples of differing G-C content, it is found that G-C
specificity increases as the visible absorbance band of
the chromophore moves to longer wavelength. This im-
plies that as the G-C pair is more polar than A-T, it
should interact more favorably with an easily polarized
chromophore (10).
Other dyes used for staining chromosomes for which
intercalation seems improbable as a result oftheir non-
coplanar arrangement, include the common triphenyl-
methane dyes such as p-fuchsin, methyl green, crystal
violet, and malachite green as well as the carcinogen
auramine. All ofthese compounds show pronounced A-
T specificity and bind to the outside of DNA in associ-
ation with the negative phosphate groups (11). They
can be removed from the DNA solutions at high salt
concentration by two or three extractions with isopro-
panol.
Dye molecules ofthe aminoacridine class have frame-
shift mutational activity and the cationic form at a neu-
tral pH form noncovalent complexes with DNA. At low
concentration, the dye intercalates, but at high concen-
trations, binding to the outside of the double helix oc-
curs (12). The intercalating dye can cause frame-shift
mutation in which a base is either inserted or deleted,
resulting in a loss of register for the triplet code. The
N-methylphenazinium cation radical formed by a one-
electron reduction of phenazine methosulfate binds to
the DNA more strongly than the cation and the DNA
stabilizes the cation radical against air oxidation and
increases cation stability (13). The binding of both cat-
ions is reversed by raising the pH or ionic strength or
by the presence of divalent cations. Binding of both
cations also does not occur with single-stranded DNA
(14). Proflavine binds equally well to double-stranded
and single-stranded DNA indicating that ionic attrac-
tion of the phosphates for the cation dye is more im-
portant. However, NMR studies confirm the existence
of7r-wr stackingbetweenadeninebasesandtheN-meth-
ylphenazinium cation radical in the intercalation model
(15).
Many antitumor drugs in clinical use may function as
a result of their ability to bind noncovalently to DNA
by intercalation (16). The anthracycline quinone, Adri-
amycin, is used to treat leukemias and solid tumors.
Adriamycin and daunomycin intercalate DNA but favor
G-C base pairs (17). This results in an increase of the
DNA melting point. This stabilization ofthe DNA dou-
ble helix could inhibit the formation of the single-
stranded templates required by DNA and RNA poly-
merase and explains the inhibition of DNA replication
and RNA transcription. Actinomycin D (containing a
phenoxazone ring and peptide loop) intercalates and
binds tightly to DNA at specific sequences (18) with a
preference for G-C basepairs and causes very strong
inhibition ofpolymerase action, particularly in some re-
gions. By using a dry bound double-stranded plasmid
pBR313 DNA and nick translation from a specific site,
the sites at which bound drug molecules interfere with
DNA polymerase action can be pinpointed. Ethidium
bromide also seems to have a preference for intercalat-
ing G-C basepairs (17,19) but this is not a strict re-
quirement. Distamycin A, with planar pyrrole rings
connected by peptide bonds, preferably binds in A-T
rich regions, probably in the minor groove (17). The
inhibition ofpolymerase action may also be relevant to
its antitumor action. The affinity ofdiacridines forDNA
are greatly increased if the linker methylene chain is
increased from four to eight carbon atoms, as both ac-
ridines can now intercalate between different pairs of
adjacent DNA bases as measured by the removal and
reversal of the supercoiling of covalently closed DNA.
Much less binding to single-stranded DNA occurs (20).
The phenothiazine derivative, chlorpromazine, is
widely used as atranquilizer and an antipsychotic drug.
The sulfoxide and the hydroxylated derivatives are the
major in vivo metabolites and are also formed from the
cation radical produced by a one-electron oxidation or
by ultraviolet irradiation (21,22). The cation radical dif-
fers from chlorpromazine in being less folded and car-
rying a positive charge. The aromatic ring systems of
phenothiazine cation radicals are flatter than phenothi-
azines as a result of less folding along the S-N axis of
the ring system (23) and explains the formation ofpar-
tial intercalation complexes with DNA. Evidence that
intercalation, rather than external binding of DNA is
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involved in the concomitant increased viscosity and the
requirement for a double helix for stabilization of the
cation radical (24). DNA shields the cation radical from
reacting with peroxidase and nucleophilic buffer con-
stituents. ESR spectral evidence of oriented DNA fi-
bers from DNA solutions spin-labeled with the radical
cation indicate that the DNA helix is perpendicular to
thearomaticmolecularplaneofcomplexedcationradical
(25). TheradicalishighlycytotoxictoSalmonellastrains
used formutagenesis studies. However, evidence ofre-
pairable DNA damage was obtained for E. coli (24).
Bioreductive Activation
Mitomycin C is an anticancer drug that is selectively
toxic to hypoxic tumor cells located in solid tumors that
contain areas of vascular insufficiency. These oxygen-
deficient cells are an obstacle to curative therapy, as
the hypoxic stem cells are relatively resistant to X-
irradiation. Mitomycin C is reduced by nuclear and mi-
crosomal NADPH-cytochrome P-450 reductase (27) to
a semiquinone radical anion (26). Loss ofmethanol and
a nucleophilic attack then results in covalent binding to
DNA to form cis and trans monofunctional adducts.
These adducts may then undergo secondary reduction
and condensation reactions to yield bifunctional adducts
which result in DNA crosslinking. The highly reactive
quinone methides may be the alkylating species in-
volved (28). Mitomycin C has also been shown to cause
DNA strand scission in vivo and in vitro. Deoxyribose
degradation readily occurs at even a low concentration
Of02. Metal chelators markedly inhibited and hydroxyl
radical scavengers partly inhibited. The responsible hy-
droxyl radicals were suggested to arise from a Fenton-
type sequence in which the semiquinone radical reacts
with H202 or reduces the ferric catalyst (29).
Although antitumor anthracycline quinone drugs
could function by noncovalent binding to DNA (16), it
is now widely accepted that radical-mediated DNA
strand breaks are more important in accounting for cell
death. The autoxidizable semiquinone-free radicalsmay
be forned by microsomal or nuclear cytochrome P-450
reductase (30). Some DNA adduct formation with se-
miquinone radicals have been reported which was sug-
gested to correlate with the ability of Adriamycin to
induce sisterchromatid exchanges (31). However, many
fewerstrandbreaksoccurredundernitrogen, indicating
that activated oxygen species were involved.
Both anthracycline quinones (Adriamycin and dau-
nomycin) have a high affinity for Fe3+, and the com-
plexes can undergo a self-reduction involving an intra-
molecuularelectrontransfer, toform aniron II complex
with the semiquinone radical (32). Superoxide radicals
arethenformedbyautoxidationofFe2 , whichcanform
H202 by dismutation and subsequently form OH by a
Fenton reaction. A species with a similar reactivity to
hydroxyl radicals seem to be responsible for the sub-
sequent degradation of deoxyribose and stimulation of
lipid peroxidation (33). The Adriamycin-Fe3+ complex
binds to DNA and catalyses its oxidative destruction.
Intercalated Adriamycin is not available for iron bind-
ing. In the presence ofthiols and 02, the DNA cleaved
(34). Furthermore, it has been found that the DNA-
Adriamycin-Fe3+ ternary complex (unlike the corre-
sponding bleomycin complex) is much more effective
than the Adriamycin-Fe3+ complex in forming hy-
droxyl radicals from H202 (35). They also proposed that
the iron chelation site of Adriamycin is between the
hydroxyl at C1l and the carbonyl at C12. One note of
caution is recent evidence that membrane binding,
rather than DNA changes, is responsible forthe ability
ofAdriamycintokilltumorcells(36). Inthisconnection,
the adriamycin-iron complex can bind to erythrocyte
ghost membranes and in the presence of glutathione
catalyzes the oxidative destruction ofthese membranes
(37). In vivo lipid peroxidation has also been reported
(38). Adriamycin also forms a strong electrostatic com-
plex with cardiolipin, a phospholipid specific for this
inner mitochonodrial membrane. The subsequent mem-
brane lipid peroxidation enables this complex to trans-
port electrons and thereby interfere with normal mi-
tochondrial electron transport (39).
Nitropyrene, nitrofurazone, and carcinogenic nitro-
furans can be reductively activated to form nitrofuran-
DNA adducts (40-42). However, in the case ofthe car-
cinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide,
the nitro anion free-radical product has been measured,
but was found not to interact with DNA (43). This sug-
gests that the DNA-reactive species is nitroso, nitrox-
ide, or hydroxylamine formed by further reduction.
DNAbinding also occurred with the oxygen-insensitive
E. coli reductase, even though no anion radical is
formed. An oxidative activation to a different range of
products with prostaglandin synthetase is also possible
(44).
Adams and Dewey first suggested that other elec-
tron-affinic compounds could mimic the radiosensitizing
effect ofoxygen on hypoxic cells. Support for this sug-
gestion is that these sensitizers have no radiation effect
on aerated cells, and the ability to sensitize is closely
correlated with the one-electron reduction potential, a
measure of electron affinity determined by pulse radi-
olysis (45). Some nitroheterocycles, however, may be
ineffective because metabolism reduces the effective
drug concentration too rapidly. Various nitrohetero-
cycles e.g., nitrofurazone, misonidazole, metronidazole
(flagyl) have been shown to increase the sensitivity of
hypoxic tumor cells to ionizing radiation. They are also
useful for their selectivity as cytotoxic agents for hy-
poxic cells. The cytotoxicity seems to involve the de-
pletion of GSH, thembrane damage and DNA damage
resulting in mutational activity. The latter may be im-
portant in explaining their carcinogenic activity. GSH
depletion may be due to GSH adduct fornation with
nitroso compounds formed followingreduction. Besides
enhancing the effect of radiation on DNA, the radi-
osensitizers also act by removing GSH, thereby pre-
venting repair processes from operating and thus fur-
ther radiosensitizing hypoxic cells. Metronidazole,
following reduction bymicrosomal reductases forms ac-
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tive metabolites which bind to DNA and have mutational
activity. The species involved may originate from hydrox-
ylanino compounds fonned following reduction (46).
Oxygen Radicals
IntheinteractionofhydroxylradicalswithDNA, 80%
of the radicals add to the bases and less than 20% ab-
stract an H atom from the sugar moiety (47). The for-
mation of 8-OH-guanine (48) and thymine glycol (49)
could prove to be useful for the determination of hy-
droxyl radical-mediated DNA damage in vivo. It has
also been proposed that OH adds to the double bond
of the nucleic acid base to generate a radical which
reacts with 02 to form a peroxyl radical. The latter
reacts with the sugar base of another nucleotide and
can result in a cleavage ofthe sugar. The sugar radical
adds oxygen and the products hydrolyze, resulting in a
strand break (50). Cleavage ofthe sugar also results in
malondialdehyde formation (51) and has been used as a
method for determining hydroxyl radicals in in vitro
systems.
Exposure ofDNA to superoxide-generating systems
causes extensive strand breakage and deoxyribose deg-
radation. Hydroxyl radical scavengers markedly pro-
tect (52). Similar results were obtained with rat liver
nuclei incubated with Fe2+/02 and may be relevant to
iron overload toxicity (53). Chromosome damage in
mammalian cells also occurred (54).
The clinical effectiveness of bleomycins, a glycopep-
tide class of antibiotics, against Hodgkins lymphomas
and squamous cell carcinomas and tumors ofthe testis,
correlates with their capability to degrade DNA. Fe2+
complexes ofbleomycin and oxygen readily cleave pBR
322 DNA, preferentially at G-C (5'-3') and G-T (5'-
3') sequences. This specificity may be due to the inter-
actionbetween the bleomycin bithiazole terminal amine
moiety and the DNA guanine base. The metal binding
site is thought to be the imidazole group. For effective
DNA strand scission, the drug must deliver a metal ion
to the site ofthe DNA helix attacked by the activated
oxygen (55). Bleomycin can also preferentially degrade
the DNA sequences in open chromatin within isolated
nuclei (56). Hydroxyl radical formation has been dem-
onstrated with certain spin traps (57) but it is not clear
whether this radical is responsible for the strand scis-
sion. DNA strand scission seems to occur as a result of
base propenal formation from an unstable 4-hydrope-
roxide formed by a radical abstraction ofthe hydrogen
from the deoxyribose C4 position. Malondialdehyde is
released in the process (58). The release of free bases,
however, is not due to a radical attack and can result
in strand scission upon alkaline treatment (59).
The formation ofactive oxygen products such as hy-
droxyl radicals from the reaction of the mitomycin C
semiquinone radical and bleomycin with oxygen may be
responsible for the life-threatening interstitial pulmo-
nary fibrosis in their clinical use (60,61). Myelosuppres-
sion occurs with most anticancer drugs, but not with
bleomycin. Whether hydroxyl radical-induced DNA
strand scission is responsible for the cytotoxicity to-
wards lung cells remains to be determined (62). Simi-
larly, hydroxyl radicals formned by the autoxidation of
the semiquinone radical formed by the reductive acti-
vation ofAdriamycin (doxorubicin) may be responsible
for the cardiomyopathy side effect (63,64). Lipid per-
oxidation readily occurs and has been implicated in the
toxicity (33,65). Only after depletion of the mitochon-
drial GSH supply does extensive lipid peroxidation and
damage to the plasma membrane ofthe intact cell occur
(66). The cardiac myocyte may be a target because of
the very low levels of catalase, superoxide dismutase,
and the unusually large number ofmitochondria in the
cell. Active oxygen species may also be responsible for
the Adriamycin-induced DNA strand scission found in
tumor cells (30,67).
Adriamycin and daunomycin also degrade deoxyri-
bose when enzymically reduced. Traces ofdioxygenand
ferric salts were required for the formation ofa species
with reactivity similar to that of a hydroxyl radical. It
is possible an activated oxygen ferrous complex is re-
sponsible (68,69). Lipid peroxidation also occurs (33)
when mitomycin C is enzymically reduced. However,
effective anticancer drugs can act against well oxygen-
ated as well as hypoxic cells in a gland tumor. Surpris-
ingly though, activated oxygen is still formed under
hypoxic conditions (29).
Toxic side effects are also a problem restricting the
clinical use of the radiosensitizer misonidazole in the
treatment of cancer. These include the development of
a peripheral neuropathy and central nervous system
damage. Nitrofurantoin treatment also results in pul-
monary edema and fibrosis. This toxicity appears to be
associated with an oxygen-sensitive reductive metab-
olism ofthe drug. The oxygen-sensitive nitroreductases
reducetheseradiosensitizers tonitro-anionfreeradicals
which are oxidized by 02 back to the radiosensitizer. In
the process, superoxide radicals and H202 are formed
and would also help to deplete GSH in the cell. DNA
single-strand breaks observed with misonidazole in cul-
tured mammalian cells (70) may be due to hydroxyl
radical formation or radicals formed from nitro-anion
free radicals.
Exposure ofisolated rat hepatocytes to2-methyl-1,4-
naphthoquinone resultsinintracellularproductionofsu-
peroxide, oxidation of glutathione, plasma membrane
bleb formation and loss of cell viability (71). A 27%
increase in the fraction of single-stranded DNA was
observed with 50 ,M menadione. DNA binding, appar-
entlybysemiquinone, wasalsoobserved. Activeoxygen
speciesarebelievedtoberesponsiblefortheglutathione
loss and DNAandmembranedamage. The DNAstrand
breaks were actively repaired. Intracellular DT-dia-
phorase, which catalyzes the two electron reduction of
menadione directly to the hydroquinone, protects the
cells from the toxic effects by competing with the one-
electron reduction pathways. Thus dicumarol, an inhib-
itor of DT diaphorase, markedly enhances cell toxicity
(72).
Active oxygen, such as superoxide and H202, has re-
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cently been shown to act as a promoter of transfor-
mation in mouse embryo fibroblasts (73) and induce
chromosomal aberrations in human lymphocytes (74).
Preneoplastictissueisusuallyattackedbyinflammatory
leukocytes. Clastogenic factors are released by these
leukocytestoinduce chromosomaldamageandinterfere
with normal intracellular metabolic cooperation asso-
ciated with tumor promotion (75,76). The clastogenic
factor may consist of free arachidonic acid and arachi-
donic acid hydroperoxides (77). Thus tumor promotion
can be prevented by superoxide dismutase or biomi-
metic analogs (particularly with catalase), antioxidants
or phospholipase inhibitors (73). These inhibitors also
preventtheinduction ofornithine decarboxylase inmice
skdn by a tumor promoter (75,78).
Oxidative Activation
Polycyclic Aromatic Hydrocarbons
A one-electron oxidation of polycycic aromatic hy-
drocarbons (PAH) canresultincationradicalformation.
The covalent binding ofPAH radical cations to nucleo-
philes depends on high localization at the most positive
carbon atom in the radical cation. If the potential is
below 7.35, the PAH binds to DNA, suggesting that
only these PAH are activated by a one-electron oxi-
dation(77). Peroxidase-hydrogen peroxidecatalyzesthe
formation of a 6-(14C)-methylbenzo(a)pyrene adduct
with DNA. NMR analysis oftheisolatedadductshowed
a covalent bond between the 6-methyl group of the 6-
methylbenzo(a)pyreneandthe2-aminogroupofdeoxy-
guanosine. A similar adduct coeluted with this adduct
in a HPLC profile in an enzymic hydrolyzate of DNA
isolated fromthemouse skin4hrafteraskinapplication
of 6-(14C)-methylbenzo(a)pyrene to mice. However,
other adducts eluting before this adduct were not iden-
tified. The expected diol-epoxide adduct was not found
(79). Itwassuggestedthattheradicalcationreactswith
nucleophilic groups ofDNA by a prior loss ofa methyl
proton and anelectrontogenerate abenzylic carbonium
ion. The 6-methylderivative was chosen because it spe-
cifically reacts with one-electron oxidants at the 6-
methyl group. Benzo(a)pyrene bindingto DNA also oc-
curs during a peroxidase-catalyzed oxidation and the
quinone products found are typical of a one-electron
oxidation (80).
N-Oxidation
Hydrazine derivatives are widely used in medicine
but often have tumorigenic and mutagenic properties.
The nature of the lesions induced in the genetic appa-
ratus is not known. A review on the biochemical toxi-
cology ofhydrazines is available (81). The monosubsti-
tuted hydrazines are readily oxidized by
oxyhemoglobin, peroxidase, prostaglandin synthetase
or cytochrome P-450 to carbon-centered radicals which
can inactivate the heme catalyst (82,83). The tumori-
genic hydrazine derivative 2-phenylethylhydrazine,
used as an antidepressant, is readily oxidized with oxy-
hemoglobin by a one-electron oxidation or microsomal
mixed function oxidase mechanism. At the same time,
strand breaks can be induced in supercoiled pBR 322
plasmid DNA, converting it to the open circular form.
Spin trapping was used to show that the carbon radical
yield correlated with the DNA nicking. Interestingly,
oxygen was not required for the nicking, even though
the inactivation of transforming DNA by other mono-
substituted hydrazine derivatives has previously been
ascribed to the active oxygen species formed (84). The
metabolically generated carbon radical is therefore re-
leased from its site of formation and can induce DNA
strand scission (81).
DNAbindingreadilyoccurredduringthe peroxidase-
H202 catalyzed oxidation of the carcinogen aminoflu-
orene, phenylenediamine and benzidine derivatives and
methylaminoazobenzene (85). Radical cations are likely
to be the first formed intermediates, so that it is of
interest to investigate the role ofthese radicals in the
binding. DNA was found to increase the stability ofthe
radical cation for chlorpromazine, benzidine, or
N,N',N,N'-(CH3)4-benzidine which, presumably, could
reflect a more planar structure, able to intercalate
DNA. The cation radical for durenediamine or phenyl-
enediamine was also stabilized by DNA, although the
cation radical for N,N-dimethylphenylenediamine was
less stable (results not shown).
Aminofluorene is oxidized by a H202-peroxidase re-
action system to a purple intermediate product absorb-
ing at 385 and 615 nm which is relatively stable at pH
5, but decays rapidly at pH 7.4. DNA stimulates the
rate of formation of this intermediate, but inhibits its
decay. Atthe sametime, the intermediate forms a com-
plex with the DNA with absorption maxima at 390 and
660 nm. The purple intermediate has been identified as
2-iminodifluorenylamine (86,87). Thus DNA enhances
the rate ofdimerization ofaminofluorene cationradicals
involved in 2,3-diaminofluorenylamine formation. Sim-
ilar results were obtained with 2,3'-difluorenylamine,
so that it is concluded that the monocation from the
imine forms a complex with DNA. Most ofthe binding
was non-covalent in nature and was removed by reduc-
tion and ethyl acetate extraction. The rest ofthe dimer
and polymers could be removed with phenol treatment
and protease treatment. However, with 14C-aminoflu-
orene, a small amount of radioactivity (approx. 0.5%)
was covalently bound to the DNA.
At a neutral pH, the aminofluorene cation radical is
probablyuncharged, and N-N couplingresultingin azo-
fluorene formation occurs. DNA seems to enhance the
rate of dimerization by the cation radicals and by com-
plexing the imine may hinder polymerization. The poly-
mer is also complexed to the DNA. Thus an ethyl
acetate extract shows much less dimer and polymer
formation in the presence of DNA (86). It is unlikely
that the DNA complexes with oxidation products in-
volve intercalation, as single-stranded DNA is twice as
effective as double-stranded DNA in binding the prod-
ucts (88). The aminofluorene DNA adduct seems to in-
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volve the guanine base and to a lesser extent adenine
as "4C-aminofluorene binds to polyriboguanylic acid
much more than polyriboadenylic acid. Little binding
occurred to polyribouridylic acid and polyribocytidylic
acid (88). DNA adduct analysis shows a small amount
of C8-guanine adduct, presumably as a result of nitro-
sofluorene fornation, butthemajorearlyelutingadduct
is unidentified (89).
Bothliverandmammaryglandofthemaleandfemale
rat, respectively, are the sites ofcarcinogenic action of
N-hydroxy-N-2-fluorenylacetamide (90). Aone-electron
oxidation ofthis carcinogen to the nitroxyl free radical
has been shown on incubating rat mammary gland cells
with arachidonate (91). A similar oxidation occurs with
peroxidase-H202 (92). Asmammaryglandhas verylow
levels of cytochrome P-450 (93), it has been suggested
that the active catalysts are lipoxygenase (91) or cy-
tochrome c (93). The nitroxyl free radicals dismutate to
equimolaramounts ofnitrosofluorene andN-acetoxy-N-
2-fluorenylacetamide, and the latter forms a covalent
adduct with nucleic acids when aperoxidase-H202 sys-
tem was used as the one-electron oxidizing system for
formingthenitroxylfreeradicals (92). Thereactive spe-
cies involved in the peroxidase-H202-catalyzed DNA
binding of N-hydroxy-N-2-fluorenylacetamide are dif-
ferent from that for aminofluorene (88).
Phenylenediaminederivatives arecomponentsofper-
manent and semipermanent hair dye formulations and
synthetic rinses. The peroxidase-H202 system also
readilyoxidizesp-phenylenediamine and2,4-diaminoan-
isole to cation radicals, which are further oxidized or
disproportionate to form a very reactive diamagnetic
benzoquinonediimine. The latter is then oxidized to tri-
mers known as Brandowski's base. DNA binding ac-
companies this oxidation at pH 5 (5). Furthermore,
DNAbinding still occurred even ifthe DNA was added
5 min after the reaction was stopped. Hydrogen per-
oxide also greatly enhances the mutagenicity ofseveral
phenylenediamines and has been attributed to the tri-
mer Brandowski's base (94). Brandowski's base was
synthesized fromp-phenylenediamine and was found to
bind to DNA to forn a purple complex only after per-
oxidase-H202 catalyzed oxidation. This suggests that
the imine derivatives ofthese trimers bind to DNA (5).
The DNA binding was resistant to extraction with or-
ganic solvents or phenol or protease incubation. How-
ever, enzymic digestion of the bound DNA to nucleo-
tides shows that most of the binding was noncovalent
in nature. Similar results were obtained with 2,4-dia-
minoanisole orp-aminophenol. Again, the DNAbinding
was due tocomplex formationwiththeimine derivative
ofthe equivalent Brandowskd's base (5).
The cation radical for p-phenylenediamine (as deter-
mined by ESR) can be stabilized by N-CH3 or O-CH3
substitution (95,96). Thus the radical cations of
N,N',N,N'-(CH3)4-p-phenylenediamine (known as
Wurster's Blue) and durenediamine arestable. Therad-
ical cations of the N-CH3 substituted p-phenylenedi-
amine exist as stable paramagnetic salts. Durenedi-
amineandN,N-(CH3)2-p-phenylenediamine didnotbind
to DNA after a peroxidase-H202 catalyzed activation.
DNAalsohad no effect ontheN-demethylation ofN,N-
(CH3)2-p-phenylenediamine as measured by HCHO for-
mation or cation radical (Wurster's Red) formation. Ca-
tion radical decay, however, was enhanced by DNA.
N,N',N,N'-(CH3)4-benzidine was much less effective
than benzidine in binding to DNA after a peroxidase-
H202 catalyzed activation. The binding was found to
occurfollowingN-demethylation. Phenol conjugate for-
mation also occurred following N-demethylation to
N,N-(CH3)2-benzidine (97).
Benzidine and benzidine congener-based dyes are
widelyusedindyemanufacturing, textiledyeing, paper
printing and leather industries (98). The incidence of
urinarybladdercancerisalsoelevated amongindustrial
workers exposed to benzidine-based dyes. Of concern
tothepublicisthatmutagens andmonoacetylbenzidine
appear in the urine ofrats orhumans treated with ben-
zidine congener-based azodyes (99). DNA-bound ben-
zidine metabolites were also found in the livers of rats
(100). Anaerobicintestinalbacteriaareprobablylargely
responsible for the azoreduction of these dyes and but
liver azoreductases could be involved in the liver car-
cinogenicity (101).
In a comparison of a wide range of various phenols
and arylamines in aperoxidase-H202reactionmixture,
the most extensive DNA binding occurred with benzi-
dine (85). Similarresults were found inanothersystem,
i.e., prostaglandinsynthetase-arachidonate (102). Blad-
der transitional epithelial microsomes from dog, on ad-
ditionofarachidonate, alsocatalyzedthebindingofben-
zidine or o-dianisidine to DNA (103). The nature ofthe
oxidationproductsincludingthefirstformed cationrad-
ical in a peroxidase-H202 catalyzed oxidation has been
reviewed (104). The effects of DNA (105) on this re-
action sequence are as follows. DNA does not affect the
conversion of benzidine to radical cation but slows the
rate offormation of quinonediimine from benzidine ca-
tion radical. DNA forms a complex with the quinone-
diimine of 3,3',5,5'-(CH3)4-benzidine, 3,3'-(CH3)2-ben-
zidine or3,3'-(OCH3)2-benzidine. This DNA interaction
results in a spectral shift ofthe absorbance maxima of
the quinonediimine of 6-12 nm to a longer wavelength.
No complex is formed with single-stranded DNA. This
suggests that the quinonediimine is planar and inter-
calates the base pairs. An electrostatic interaction be-
tween the monoprotonated diimine and the negative
charge on the sugar phosphate groups may also be in-
volved.
In the case of benzidine and 3,3'-(CH3)2-benzidine,
DNA catalyzes a rapid decay of synthesized quinone-
diimine. At pH 6.5, azo compounds and polymerare the
products but are bound to the DNA and cannot be ex-
tracted with ethyl acetate (85). AtpH 5, astable charge
transfer complex and polymer bind to the DNA. The
DNA therefore accelerates the conversion of quinone-
diimine to azo and polymer compounds. With single-
stranded DNA and polyribonucleotides, no bound
charge-transfer complex was formed although quino-
nediiminedecaywasaccelerated. Thissuggeststhatthe
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intercalated diimine can form a charge-transfer com-
plex. The reaction mixture containing DNA forms a
thick gel if the DNA is at a concentration of 1 mg/mL
which could also explain the stability of the charge-
transfer complex.
MgCl2couldpreventtheenhancedquinonediiminede-
cay by DNA suggesting that the negative phosphate
groups of the DNA were involved. Up to 97% of the
benzidine binds to the DNA following a peroxidase-cat-
alyzed oxidation. The bound benzidine is not removed
by butanol extraction, by phenol treatment, or pronase
digestion. However, acid digestion releases the bound
benzidine as polymeric material. Most of the bound
DNA resists enzymic digestion by DNAase, phospho-
diesterase, or alkaline phosphatase. Of the nucleotide:
benzidine adducts, 7% extractinton-butanol. Separation
ofthe adducts on HPLC showed that the major adduct
(82% of the radioactivity) had a UV spectra with an
absorbance maxima at 295 nm and a shoulder at 265
nm. The adduct was also degraded by 70°C for 1 hr or
on adjusting the pH to 1 resulting in its conversion to
an adduct having a maximal absorbance at 255 nm (85).
These properties were similar to those reported forthe
N-acetylbenzidine adduct formed in rat liver in vivo
(105), suggesting that the adduct is N-(deoxyguanosin-
8-yl)-benzidine.
Recently, a N-acetylcysteine conjugate has been iso-
lated from a peroxidase-H202-benzidine-N-acetyl-
cysteinereactionmixtureandalsoidentifiedas3-(N-acet-
ylcysteine-S-yl)-benzidine (106). An analogous GSH
conjugate has also been isolated from a prostaglandin
H synthase-arachnidonate-benzidine-GSH reaction
mixture (107). The DNA adducts isolated from the dog
bladder after the in vivo 14C-benzidine administration
was 10% N-(deoxyguanosin-8-yl)[N'-acetylbenzidine
but the rest was unidentified. In dogliver, less than 1%
ofthe adducts were identified as this adduct (108). Re-
cently, the N-(deoxyguanosin-8-yl)-benzidine has been
identified as the major adduct isolated from the dog
bladder. A similar adduct was found when benzidine-
diimine was reacted with DNA (109).
A comparison of the various benzidine derivatives
show that all ofthem bind to the DNA except 3,3',5,5'-
(CH3)4-benzidine (110,111). This suggests that an un-
substituted ortho position is required for binding. This
derivative is also noncarcinogenic in short-term tests
(112), and azo dyes haverecently been prepared forthis
derivative with the hope ofmakingnoncarcinogenic azo
dyes available (113).
The above results also suggest that the major part of
the binding may involve very tightly bound benzidine
"melanin" which prevents enzymic digestion. Benzidine
bound polyriboguanylic acid also resisted ribonuclease
digestion. This suggests thatsuchbindinginvivo would
not be repairable and should be highly cytotoxic.
When covalently closed circular plasmid DNA pBR
322isreactedwith the benzidine oxidation products and
subjected to gel electrophoresis, the bound DNA did
not migrate or enter the gel. This suggests extensive
crosslinking as the reaction conditions did not involve
gel formation, and intercalation seems unlikely, as the
DNA still stained with ethidium bromide. Crosslinking
was suggested to involve the benzidine diimine acting
as a bifunctional alkylating agent (85).
N,N-Dimethyl-4-aminoazobenzene (DAB) is a well
known liver carcinogen in rats and induces bladder tu-
mors in dogs. Nonextractable DNAbinding occurs dur-
ingtheN-dealkylation catalyzed by a peroxidase-H202
system. Methyl-4-aminoazobenzene (MAB) bound more
effectively. Bladder microsomes and arachidonate also
catalyzed this DNAbinding. This was prevented bythe
prostaglandin synthetase inhibitor indomethacin (114).
Lipid peroxides in the presence ofheme also catalyzed
theN-dealkylation ofDAB, andinthepresence ofGSH,
the GSH conjugate GS-CH2-aminoazobenzene was iso-
lated (86). This conjugate was also isolated from a re-
action mixture ofperoxidase-H202-MAB. When DAB
is given in uninduced rats, the GS-CH2-aminoazoben-
zene forms the major biliary metabolites. Indeed GSH
depletion in vivo markedly decreased the biliary excre-
tion 1 (115). It is believed that this GSH conjugate is
formed duringN-demethylation ofMAB bycytochrome
P-450-dependent mixed-function oxidase. It is interest-
ingthat the same conjugate may also be formed by one-
electron oxidative systems involving free radicals.
The main products formed by the peroxidase cata-
lyzed oxidation ofMAB at a neutral pH were identified
as dimers formed by N-N coupling whereas at pH 5, N-
C coupling predominated. The DNA binding was no-
nextractable and up to 5% ofthe MAB could be bound.
However, the binding was noncovalent and enzymic
digestion was required to release the radioactivity. A
spectral analysis ofthe MAB bound DNA showed that
the binding species was a dimer or polymer.
Many carcinogenic or genotoxic arylamines, e.g., 4-
aminobiphenyl, 2-aminofluorene and benzidine or phen-
ylenediamine derivatives are N-acetylated by the liver
in many species in vivo. Little N-acetylation, however,
occurs in the dog. Furthermore, the target organ in
rodent species is the liver but in the dog, it is the blad-
der. N-acetylated arylamine:DNA adducts are among
the DNA adducts isolated from rodent liver after the
invivo administration ofthese carcinogenic arylamines.
By contrast, the adducts isolated from rodent nonhe-
patic tissues or dog liver were not acetylated (5). This
suggests that the N-acetylated adducts may play a role
in liver cancer. We have shown that N-acetylation of
these arylamines prevents their oxidation by various
one-electron oxidizing systems and enhances their rate
of N-hydroxylation by liver cytochrome P-450-depen-
dent mixed-function oxidase. However, in the presence
oflivermicrosomes oresterase, theN-acetylarylamines
are readily oxidized by one-electron oxidizing systems
and that paraoxon completely prevents this oxidation
to DNA reactive species. Clearly microsomal deacety-
lase activity is involved in this activation (88,116). The
acetylase activity versus the deacetylase activity of a
tissue may therefore be as important as the "peroxi-
dase" activity versus the mixed-function oxidase activ-
ity in deciding whether free radicals are involved in the
activation ofthesearylaminesbyvarioustargettissues.
Thus, the Zymbal gland may be an important target
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organ because of its high deacetylase activity and per-
oxidase activity (88).
Phenols
Diethylstilbestrol induces genital tract tumors in
young women whose mothers were treated with this
synthetic estrogen during gestation. It is also carcino-
genic in rodents. The hornonal activity ofthis estrogen
is not sufficient to explain its tumorgenicity (117,118).
The uterus has an estrogen-inducible peroxidase and
prostaglandin synthetase activity (but no mixed-func-
tion oxidase activity) and peroxidative metabolism re-
sults in DNA binding (119,120) and genotoxic effects
not including bacterial mutagenicity (121). In a recent
study of various analogs, it was concluded that only
those able to form phenoxy radicals bound and that the
stilbene moiety was not required (122). The phenoxy
radical (diethylstilbestrol-4',4"-semiquinone) is an in-
termediate for the formation of 4',4"-quinone which in
protic solvents is converted to dienestrol. This conver-
sion also occurs in vivo (121). It has been shown that
DNA catalyzes the conversion of quinone to dienestrol
andthatinthe process, thequinone bindstocalfthymus
DNA. The binding decreases with increasing reaction
time (123). The bound diethylstilbestrol cannot be re-
moved, butnobound nucleotideswere foundonenzymic
digestionwhichindicatesthatthebindingisnoncovalent
(unpublished data).
A chronic exposure ofbenzene produces hemopoietic
toxicity and in severe cases results in aplastic anemia.
It has also been implicated as a leukemogen (124). Ben-
zene requires metabolic activation to produce its tox-
icity and ametabolite ofphenol, not benzene oxide, was
responsible for the majority ofinvitro covalent binding
to microsomal protein (125). Recently, we have shown
that a peroxidase found in bone marrow oxidizes 14C-
phenolto various dimers andpolymers viaphenoxyrad-
icals and in the process, up to 50% ofthe radioactivity
bound to DNA (126). No catechol or hydroquinone was
formed. No DNAbindingoccurred with the microsomal
mixed-function oxidase with phenol, hydroquinone or
catechol although protein bindingdid occur. Phenol was
metabolizedtohydroquinone andcatecholinthissystem
(127). Binding to mitochondrial DNA in rabbit bone
marrow incubated with 14C-benzene has also been re-
portedrecently (128). The nature ofthereactive species
formed from phenoxy radicals that bound to DNA was
found to be a polymer of 5 phenol residues formed in
the reaction mixture from o,o-biphenoxy and phenoxy
radicals. Most of the binding was non-extractable but
noncovalent as enzymic digestion released the radio-
activity (129).
Ellipticine has been found to be an effective drug
againstmurine leukemia L210 and several solid tumors.
Themechanism seemstoinvolve ametabolic conversion
to the 9-hydroxy derivative which can intercalate DNA
or undergo a one-electron oxidative activation to au-
toxidisable quinoneimine radicals which can bind to or
damage DNA or bind covalently to protein (130,131).
The anticancer drug etoposide (VP-16) has been shown
to form aphenoxyradicalonoxidation byaperoxidase-
H202-system. This radical has been implicated in the
DNA-breakage and cytotoxicity (132).
Polyunsaturated Fatty Acids
Carcinogenesis induced bychlorinatedhydrocarbons,
hydrazines, hypolipidemic drugs or choline-methionine
deficiency is associated with in vivo lipid peroxidation
(133). In the case of chlorinated hydrocarbons or hy-
drazines, various radical or electrophilic metabolites
could also be responsible for initiating the carcinogen-
esis. The induction of peroxisomes by hypolipidemic
drugs suggests that H202 could also be involved in the
initiation (134). However, the only initiating species re-
ported for the induction of liver cancer by a choline-
methionine-deficient diet (intheabsence ofadded chem-
ical carcinogens) may be formed as a result of the as-
sociated lipid peroxidation in the nuclei (135,136).
Various studies have appeared on the modification of
DNA by lipid peroxidation. DNA isolated from a ves-
icular gland microsome-14C-arachidonate reaction mix-
ture was found to be irreversibly bound with 14C-ar-
achidonate oxidation products. Furthermore, DNA
isolated from a peroxidizing arachidonate reaction mix-
ture containing microsomes from lung, kidney, plate-
lets, brain and testes was found to fluoresce with Eexcit
at 350 nm and Eem at 430 nm. Prostaglandin synthetase
appeared to be the catalyst as indomethacin prevented
this (137). The similarity ofthis fluorescence to lipofus-
cin and to DNA reacted with a malondialdehyde, a
breakdown product of lipid peroxides, (138) suggests
that aldehyde decomposition products may react with
the amine groups of nucleic acid bases to form fluores-
cent Schiff bases. DNA reacted with malondialdehyde
at pH 4.2 or temperatures exceeding 60°C results in a
loss of template activity and decreased hyperchromic-
ity, probablyasaresultofinterstrandcrosslinking. This
has recently been demonstrated in liver and testes nu-
clei isolated after feeding 1,3-propanediol to rats sug-
gesting that the crosslinking is not repairable in vivo
(139). The crosslinking seems to involve interstrand
guanine-cytosine bases in the interior of DNA rather
than paired bases which could explain why they may
not easily be recognized by a repair system. Enzymic
digestion by the DNA, however, failed to release flu-
orescent nucleotide adducts. Malondialdehyde also
crosslinked DNA to histones (138). However, the mu-
tagenicity ofmalondialdehyde is probably due to DNA
adduct formation rather than interstrand crosslinking
or polymerization (140).
Incubation oflinoleic acid hydroperoxide with super-
coiled pBR 322 plasmid resulted in nicking ofthe DNA.
The site ofcleavage was determined by DNA sequence
analysis using 3'-end and 5'-end-labeled DNA frag-
ments as substrates. Cleavage occurred at the position
ofguanine nucleotide (141), presumablyfollowingaper-
oxyradicalattackofthepurinering. Single-strand DNA
breaks can also be produced in isolated rat liver nuclei
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with organic peroxy radicals (142). ESR evidence by
other investigators indicates that a guanine radical is
formedwhichisstabilizedinthe DNA. Polyriboguanylic
acid, but not other polyribonucleotides, gave a similar
signal (143). The energy ofthe highest occupied molec-
ular orbital ofguanine is the highest and thus the most
easily oxidized ofthe nucleic acid bases (144).
Oxidative Activation in Intact Cells
Thepolymorphonuclearleukocytehasapowerfuloxy-
gen activation mechanism used to carry out its bacte-
ricidal function. Phagocytosis or interaction of the
plasma membrane with a variety ofstimulatory agents
(including the tumor promoter phorbol myristate ace-
tate) results in a greatly increased cyanide respiration
leading to the production of activated oxygen species.
We have shown that 14C-phenol, benzidine, N-methyl-
aminoazobenzene, and aminofluorene incubated with
leukocytes are co-oxidized and bind irreversibly to leu-
kocytenuclearDNAonlyiftheleukocytesare activated
(85,149,150). Thebindingwas dependent on oxygenand
was decreased by sulfhydryl inhibitors and phenolic an-
tioxidants that inhibit the respiratory burst triggered
by the phorbol myristate. Both the binding and the
respiratory burst were increased by low concentrations
ofazide, presumably asaresultofenhanced H202levels
duetointracellularcatalaseinhibition. However, higher
azide and cyanide concentrations prevented binding
without affecting the respiratory burst, indicating that
myeloperoxidase is a catalyst for the binding. Granules
from the activated leukocytes or myeloperoxidase also
catalyzed extensive binding to calf thymus DNA with
H202 and had a similar sensitivity to cyanide as the
leukocytes. A 20- to 40-fold higher level ofbinding was
found, indicating that proteins and hydrogen donors
protect the nuclear DNA in the intact cell (150). A leu-
kocyte-catalyzed activation of carcinogens may play a
role in explaining the enhanced incidence ofcancer as-
sociated with chronic inflammatory states. Further-
more, these cells or precursor cells found in bone mar-
row may play a role in benzene-induced leukemia as a
result of activation ofthe phenol metabolite.
ofazide, presumably as aresult ofenhanced H202levels
duetointracellularcatalaseinhibition. However, higher
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without affecting the respiratory burst, indicating that
myeloperoxidase is a catalyst for the binding. Granules
from the activated leukocytes or myeloperoxidase also
catalyzed extensive binding to calf thymus DNA with
H202 and had a similar sensitivity to cyanide as the
leukocytes. A 20- to 40-fold higher level ofbinding was
found, indicating that proteins and hydrogen donors
protect the nuclear DNA in the intact cell (150). A leu-
kocyte-catalyzed activation of carcinogens may play a
role in explaining the enhanced incidence of cancer as-
sociated with chronic inflammatory states. Further-
more, these cells or precursor cells found in bone mar-
row may play a role in benzene-induced leukemia as a
result ofactivation ofthe phenol metabolite.
Photoactivation
Photodermatological toxic reactions can often occur
withinafewhoursoftakingcertaindrugs. Photoallergic
reactions involving an immunological mechanism is
often involved resultingin eczema orbullous eruptions.
These drugs include the tranqulllizer phenothiazines
(e.g., chlorpromazine andpromazine); theantihistamine
phenothiazines (e.g., promethazine); the antibiotic te-
tracycline, and anticancer anthracycines. The reactive
species formed that bind to macromolecules or cause
membrane damage often include organic radicals or hy-
droxyl radicals.
Promazine photoexitation results in the formation of
cation and hydroxy radicals which cause DNA single-
strand breaks but do not photobind (151). The hydroxy
radical is suggested to be formed by a Haber-Weiss
reaction from superoxide formed by a reactionbetween
molecular oxygen and the photoejected electrons. Pho-
toexcited chlorpromazine rapidlyundergoes photodech-
lorination, yielding chlorine and promazynyl radicals
which photobind to the guanine of DNA (152). Chlor-
promazine complexed with DNA photobinds much less
readily (152). The anthracycine antitumor agent, dau-
nomycin, can produce photodermatological side effects
including contact dermatitis and severe skin damage.
Photosensitized daunomycin can result in hydroxyl rad-
ical mediated DNA strand breaks (153).
Light and acridine orange induce the formation of
peroxide radicals in DNA (154). It is believed that the
excited dye triplet state reacts with thymine to form
anion radicals and with guanine to form cation radicals.
Photosensitized guanine modification and hydroxyl rad-
icalmediated DNA strandbreakage withproflavine has
been reported (155). Base substituted mutations are
also formed rather than the frame-shift mutations
formed in the dark (156).
A mixture of hematoporphyrin derivatives, when
givenintravenously, isretainedselectivelyinmalignant
tumor and tumornecrosis occurs when red light is then
applied to the tumor (157). This method is now used in
the treatment of various cutaneous and cancers of the
bladder, bronchii, and gynecological organs. Guanine
residues ofDNA are modified by the singlet oxygen or
hydroxyl radicals formed. Hydroxyl radical formation
in cellular species has been detected by 5,6-dihydroxy-
dihydrothimine formation and spin adduct formation
(158).
Blood transfusion can result in the transmission of
Chagas disease and the triarylmethane dye, gentian vi-
olet (crystal violet) is widely used by blood banks in
attempts to eliminate this. Gentian violet is also used
for the control offungal and intestinal parasites in hu-
mans. Visible light also catalyzes the trypanocidal ef-
fects of the triarylmethane dye, gentian violet (159).
Light acts by catalyzing the reductive activation by a
hydrogen donor to a carbon-centered free radical as
demonstrated by ESR. Genetic toxicity was also en-
hanced (160).
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Conclusion
Free-radical metabolites can be generated metaboli-
cally by aone-electron reductase-catalyzed reduction or
a"peroxidase" catalyzed oxidationorbyphotoactivation
ofa wide variety ofaromatic xenobiotics. Radicals may
also be generated during lipid peroxidation. Some rad-
icals can react with DNA directly and probably result
in guanine radical formation. Other radicals may inter-
calate DNA or bind covalently or noncovalently as a
dismutation product or as a dimer, trimer or polymeric
product. Modification to the DNA can result in single-
strand breaks, loss oftemplate activity, and crosslink-
ing. Thebindingcanpreventenzymicdigestion. Insome
cases, the radicals react with oxygen, resulting initially
in its reduction to superoxide anion radical before con-
version to DNA reactive oxygen species. Most radicals
probably do not interact with DNA.
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